Clinical Trial Details

EORTC-20855

Back to Clinical Trials Database

Phase III trial comparing CHVmP/VCR-BLM vs modified ProMACE/MOPP regimen for patients with stages II, III, IV lymphomas of intermediate and high grade malignancy

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 15-Jan-1986
Date Step1 close: 10-Jan-1991
Data management at EORTC Yes
Design Phase 3
Randomized open
Targeted Sample size EORTC Groups: 300
Treatment
Study Staff
Type of cancer
Participating groups EORTC Lymphoma Group
Participating centers
Protocol summary http://clinicaltrials.gov/ct/show/
NCT number